hotspot -WSS

hotspot

author：hotspot 2025-09-29 01:38:35 - browse：44692

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

WSS

WuXi Biologics beefs up its lobbying operation

As H5N1 spreads in cows, experts warn against drinking raw milk

ALS treatment from Biogen, Ionis fails in study

Obesity drug from Roche shows promise in early study

WuXi Biologics execs register to lobby as Congress comes for the company

The White House hikes tariffs on plastic syringes made in China

hotspot

hotspot

explore

Dobbs anniversary: the lost opportunity of abortion as health care

J&J expands global access to TB drug amid advocacy campaign

Psychedelics group wrestles with new pharma identity

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Drug repurposing or repositioning? The language matters

WuXi Biologics beefs up its lobbying operation

Guidelines to prevent youth baseball injuries need more muscle

Novo Nordisk testing Wegovy against alcohol

Medical records are filled with copy

Novo Nordisk testing Wegovy against alcohol

explore

Supreme Court to hear if Covid misinformation is protected speech

Woman gored by Bison at Yellowstone

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Abbott's new stent may help patients with peripheral artery disease

Who gets to use the title 'doctor'?

Georgia court denies Trump's request to quash DA's 2020 election probe

knowledge

focus

explore

hotspot